Falsificação de medicamento: Anvisa participa de evento
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5411665
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5411665
March 19, 2019
Our file number: 19-101967-390
Under the Regulatory Review of Drugs and Devices initiative, Health Canada is increasing the efficiency of the regulatory system and supporting timely access to therapeutic products. As part of this initiative, Health Canada is pleased to announce the launch of the e-Learning tool, Understanding How Medical Devices are Regulated in Canada – Premarket Regulation.
This web-based tool, designed as an interactive learning platform, offers an overview of Health Canada’s premarket regulatory requirements for medical devices. It also provides targeted guidance to enable greater consistency in the understanding, interpretation and application of the Food and Drugs Act, the Medical Devices Regulations and their related policies and guidelines.
The tool serves as a valuable, comprehensive, and organized source of premarket regulatory information for various medical device stakeholder groups, including manufacturers, importers, distributors, consultants, healthcare groups, and academia. By providing e-Learning content to manufacturers and other relevant stakeholders, it is expected that the completeness and quality of Medical Device Licence applications will improve, thereby resulting in more positive, and more timely, regulatory decisions.
Health Canada encourages and invites stakeholders to utilize and benefit from this new educational tool.
Questions or concerns regarding this notice or the e-Learning tool should be directed to the Medical Devices Bureau at hc.mdb.enquiries-enquetes.bmm.sc@canada.ca.
Nos complace compartir invitación al programa de webinars de la Red de Evaluación de Tecnologías en Salud de las Américas (RedETSA) el día 29 de marzo a las 11am (EST), en la cual el Lic. Alfredo Palacios, del Instituto de Efectividad Clínica y Sanitaria (IECS) hará una presentación sobre “Modelo web de análisis de impacto presupuestario”.
El link de WebEx que utilizaremos es el siguiente: https://goo.gl/Rxrxki
On 15 March 2019, the Ministry of Public Health in Niger issued a call for vigilance regarding the circulation of falsified Mencevax ACWY vaccines. This WHO medical product alert provides the details of those products which have been confirmed as falsified to date. Inquiries indicate that the supply chain route of these falsified
vaccines includes other countries in West Africa: as such, increased vigilance is requested in all countries of the region, at all levels of the supply chain.
http://www.who.int/entity/medicines/publications/drugalerts/drug_alert-5-2019/en/index.html
Performance Series Sagittal Blade (2019-03-18)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69434r-eng.php
Phenobarb Elixir (2019-03-29)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69462r-eng.php
Tobramicina inhalatoria en polvo versus tobramicina inhalatoria en solución en fibrosis quística/Tobramycin inhalation powder versus tobramycin inhalation solution for cystic fibrosis
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.987042
Cabazitaxel, abiraterona y enzalutamida en cáncer de próstata metastásico resistente a la castración con fracaso a docetaxel/Cabazitaxel, abiraterone and enzalutamide in metastatic castration-resistant prostate cancer not responding to docetaxel
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.987026
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5409406